Bioequivalence and Bioavailability Forum • Add-on Studies / Sequential Design

Add-on Studies / Sequential Design [Design Issues]

posted by joyjac – Philippines, 2006-07-19 07:10 (6488 d 14:27 ago) – Posting: # 179
Views: 11,282

I have some questions regarding add-on studies /sequential design.

Are these acceptable in bioequivalence studies if specified a priori in the protocol? Would you know if US FDA, EMEA, Canada, ASEAN accept such design?
When an add-on study is conducted (and combined with the original study), what would be the statistical method of analysis?
Can we still apply the 90% Confidence Interval criteria for bioequivalence or would it have to be more restrictive i.e. 95% CI?
Could the first study be discarded if the second study passed the 90% CI BE criteria on its own?
More importantly, what are its pros and cons with regards to consumer protection or risk.

Thank you so much for the knowledge sharing.